Ainos Inc

General ticker "AIMD" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $5.1M

Ainos Inc does not follow the US Stock Market performance with the rate: -38.6%.

Estimated limits based on current volatility of 5.6%: low 0.44$, high 0.49$

Factors to consider:

  • Current price 68.5% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.49$, 4.11$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.32$, 3.55$]

Financial Metrics affecting the AIMD estimates:

  • Negative: Non-GAAP EPS, $ of -3.27 <= 0.10
  • Negative: Operating profit margin, % of -99.08 <= 1.03
  • Negative: Operating cash flow per share per price, % of -29.21 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0.04 <= 0.14

Similar symbols

Short-term AIMD quotes

Long-term AIMD plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.59MM $3.52MM $0.12MM
Operating Expenses $4.46MM $17.50MM $13.33MM
Operating Income $-3.87MM $-13.98MM $-13.21MM
Non-Operating Income $-0.02MM $-0.03MM $-0.56MM
Interest Expense $0.02MM $0.05MM $0.14MM
R&D Expense $1.92MM $6.85MM $7.32MM
Income(Loss) $-3.89MM $-14.01MM $-13.77MM
Taxes $0.00MM $0.00MM $0.00MM
Profit(Loss) $-3.89MM $-14.01MM $-13.77MM
Stockholders Equity $10.20MM $34.63MM $24.45MM
Inventory $0.00MM $0.60MM $0.17MM
Assets $40.82MM $37.11MM $31.84MM
Operating Cash Flow $-1.25MM $-3.02MM $-4.69MM
Capital expenditure $0.14MM $0.63MM $0.09MM
Investing Cash Flow $-0.18MM $-0.63MM $-0.10MM
Financing Cash Flow $3.15MM $3.83MM $4.92MM
Earnings Per Share* $-2.59 $-5.15 $-3.36

* EPS are Split Adjusted, recent splits may be reflected with a delay.